MedTrace Logo

The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients

NCT03377816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2023-10-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine two mechanistic changes: emotion processing (awareness, expression and acceptance) and cholinergic anti-inflammatory processes (HRV and cytokine expression) through which an Art Therapy (AT) intervention reduces depression, pain and fatigue.

Conditions

Interventions

BEHAVIORAL

Art Therapy

In a group setting participants will be encouraged to engage in art making for increased emotional awareness, expression, and acceptance. The role of the art therapist is to encourage a non-judgmental and exploratory approach to artmaking in which the process is emphasized over product. The art therapist obtains these goals by creating an atmosphere that is calm and by remaining tuned in to the verbalizations and body language of participants. If needed she can provide individual attention that is geared toward neutralizing concerns regarding performance during the art making.

BEHAVIORAL

Sham Art Therapy

In a group setting participants will engage in Mandala coloring

Sponsors & Collaborators

  • University of Arizona

    collaborator OTHER

  • Monash University

    collaborator OTHER

  • Rabin Medical Center

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of Haifa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-11
Primary Completion
2022-06-10
Completion
2022-06-10

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377816 on ClinicalTrials.gov